Embecta EMBC
NASDAQ EMBC
$6.43 +0.02 (+0.31%)
At close: Nov 10, 2026 · 4:00 PM EST

Embecta (EMBC) Return on Equity [ROE] (2021)

Updated

Embecta's Return on Equity [ROE] was 71.33% in fiscal Q1 2022 (quarter ended Dec 31, 2021), up 0.49 percentage points from the prior quarter.

Analysis

Embecta (EMBC) Return on Equity [ROE] (2021) Analysis & Trends

For FY2021 (ended Sep 30, 2021), Return on Equity [ROE] at Embecta came in at 71.12%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 13.20%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 9.09%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 8.15%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 17.28%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 17.46%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -4.01%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 13.69%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 9.36%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 4.56%
10 Embecta 364.32 Mn -462.08 Mn 153.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 71.33%
Sep 30, 2021 70.85%
Jun 30, 2021 73.13%
API Access

Embecta Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EMBC&period=max&api_key=YOUR_API_KEY